BioPort
Diphtheria & Tetanus Toxoids Adsorbed; DT vaccine
Status: withdrawn from the market
Organizations involved:
BioPort Corp. – Manuf.; R&D; Tech.
Michigan Biologics Products Institute – Former
Cross ref: See the entries for the component vaccines, Diphtheria Toxoid Adsorbed (#419) and Tetanus Toxoid Adsorbed (#551) from BioPort. See the entry for Diphtheria & Tetanus Toxoids & Pertussis Vaccine Adsorbed (DTP vaccine) (#448) manufactured by BioPort Corp., of which this DT vaccine is a component. See the Diphtheria & Tetanus and Pertussis Vaccines (DTP/DTaP) Products entry (#429). See the Tetanus Toxoid Vaccine (#543) and Diphtheria Toxoid Products entries (#418).
Description: Diphtheria & Tetanus Toxoids Adsorbed is a combination vaccine formulated by mixture of two vaccines – Tetanus Toxoid Adsorbed and Diphtheria Toxoid Adsorbed (see related entries).
Nomenclature: Diphtheria & Tetanus Toxoids/BioPort [BIO]; Diphtheria & Tetanus Toxoids Adsorbed [FDA]; Diphtheria & Tetanus Toxoids Aluminum Phosphate Adsorbed [FDA former]; DT Vaccine [SY]
Companies.: Diphtheria & Tetanus Toxoids Adsorbed was manufactured by the Michigan Department of Public Health (CBER/FDA est. no. 0099), later the Michigan Biologics Products Institute; later, now BioPort Corp. (CBER/FDA est. 1260).
SmithKline Beecham Corp. (now GlaxoSmithKline Inc.) previously marketed a Diphtheria and Tetanus Toxoids and Pertussis Vaccine Adsorbed (DTP) product in the U.S., using components manufactured by the Michigan Biologics Products Institute (now BioPort Corp.).
FDA class: Biologic PLA
CBER class: Multiple Antigen Preparations
Approvals: Date = 19510511; first approval granted to Michigan Dept. of Public Health, according to 1979 Office of Technology Assessment vaccines approvals list
Date = 19550000; first approval according to BioPort Web site (on 3/16/2000)
Date = 19700827; first approval granted to Michigan Department of Public Health, according to the CBER/FDA BRMS database. However, an FDA letter to the company on this date states that the product license was revoked and granted (reissued) using the current FDA proper name.
Date = 19981112; licenses (PLA/ELA) revoked and granted (reissued) to new owner, BioPort Corp.
Date = 20000803; license voluntarily revoked
Indications: product insert/labeling not available
Status: The product is no longer approved, manufactured, or marketed. License revocation was announced in the Federal Register, May 29, 2001, (66) 103, p. 29148-9.
Companies involvement:
Full monograph
425 Diphtheria & Tetanus Toxoids/
Nomenclature:
Diphtheria & Tetanus Toxoids/BioPort [BIO]
Diphtheria & Tetanus Toxoids Adsorbed [FDA]
Diphtheria & Tetanus Toxoids Aluminum Phosphate Adsorbed [FDA former]
DT Vaccine [SY]
FDA Class: BiologicPLA
Year of approval (FDA) = 1951
Date of 1st FDA approval = 19510511
(in format YYYYMMDD)
Index Terms:
biopharmaceutical products
vaccines, bacterial
vaccines, combination
vaccines, toxoids (inactivated toxins)
bacterial culture <!-- bacterialculture -->
Clostridium tetani
Corynebacterium diphtheriae
aluminum phosphate
Diphtheria Toxoid
formaldehyde
Tetanus Toxoid
thimerosal (mercury derivative)
approval dates uncertain (FDA reports erroneous, conflicting, or simply has lost the original approval dates) (FDAapproved)
approval dates uncertain (FDA reports erroneous, conflicting, or simply has lost the original approval dates) (FDAapproved)
approval dates uncertain (FDA reports erroneous, conflicting, or simply has lost the original approval dates) (FDAapproved)
North American coral snake
North American coral snake
EU000 Not yet/Never filed with EU
UM999 Not Available/Not Marketed in US
US011 Approved Formerly in US/withdrawn
EM999 Not Available/Not Marketed in EU
Copyright© 2020, Biotechnology Information Institute